PD-1/PD-L1 Control of Antigen-Specifically Activated CD4 T-Cells of Neonates

被引:6
|
作者
Majer, Christiane [1 ]
Lingel, Holger [1 ]
Arra, Aditya [1 ]
Heuft, Hans-Gert [2 ]
Bretschneider, Dirk [3 ]
Balk, Silke [1 ]
Vogel, Katrin [1 ]
Brunner-Weinzierl, Monika C. [1 ]
机构
[1] Otto von Guericke Univ, Med Fac, Dept Expt Pediat, D-39120 Magdeburg, Germany
[2] Otto von Guericke Univ, Med Fac, Inst Transfus Med & Immunohematol, D-39120 Magdeburg, Germany
[3] Hosp Sankt Marienstift, Matern Clin, D-39110 Magdeburg, Germany
关键词
T-helper cells; CD4 T cell; immune checkpoint molecule; PD-1; PD-L1; Staphylococcus aureus (S; aureus); bacteria; staphylococcus enterotoxin B (SEB); pediatric immunology; newborn; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC EXPOSURE; CTLA-4; CD152; POPULATION; EXPRESSION; CHILDREN; INFANTS; RISE;
D O I
10.3390/ijms24065662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Newborns are highly susceptible to infections; however, the underlying mechanisms that regulate the anti-microbial T-helper cells shortly after birth remain incompletely understood. To address neonatal antigen-specific human T-cell responses against bacteria, Staphylococcus aureus (S. aureus) was used as a model pathogen and comparatively analyzed in terms of the polyclonal staphylococcal enterotoxin B (SEB) superantigen responses. Here, we report that neonatal CD4 T-cells perform activation-induced events upon S. aureus/APC-encounter including the expression of CD40L and PD-1, as well as the production of Th1 cytokines, concomitant to T-cell proliferation. The application of a multiple regression analysis revealed that the proliferation of neonatal T-helper cells was determined by sex, IL-2 receptor expression and the impact of the PD-1/PD-L1 blockade. Indeed, the treatment of S. aureus-activated neonatal T-helper cells with PD-1 and PD-L1 blocking antibodies revealed the specific regulation of the immediate neonatal T-cell responses with respect to the proliferation and frequencies of IFN gamma producers, which resembled in part the response of adults' memory T-cells. Intriguingly, the generation of multifunctional T-helper cells was regulated by the PD-1/PD-L1 axis exclusively in the neonatal CD4 T-cell lineage. Together, albeit missing memory T-cells in neonates, their unexperienced CD4 T-cells are well adapted to mount immediate and strong anti-bacterial responses that are tightly controlled by the PD-1/PD-L1 axis, thereby resembling the regulation of recalled memory T-cells of adults.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
    Escors, David
    Bocanegra, Ana
    Chocarro, Luisa
    Blanco, Ester
    Pineiro-Hermida, Sergio
    Garnica, Maider
    Fernandez-Rubio, Leticia
    Vera, Ruth
    Arasanz, Hugo
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [2] Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
    Haspot, Fabienne
    Fehr, Thomas
    Gibbons, Carrie
    Zhao, Guiling
    Hogan, Timothy
    Honjo, Tasuku
    Freeman, Gordon J.
    Sykes, Megan
    BLOOD, 2008, 112 (05) : 2149 - 2155
  • [3] Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade
    Martinez-Gomez, Carlos
    Michelas, Marie
    Scarlata, Clara-Maria
    Salvioni, Anna
    Gomez-Roca, Carlos
    Sarradin, Victor
    Lauzeral-Vizcaino, Francoise
    Feliu, Virginie
    Dupret-Bories, Agnes
    Ferron, Gwenael
    Sarini, Jerome
    Devaud, Christel
    Delord, Jean-Pierre
    Balanca, Camille-Charlotte
    Martinez, Alejandra
    Ayyoub, Maha
    CANCERS, 2022, 14 (15)
  • [4] PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus
    Marchevsky, Alberto M.
    Watts, Ann E.
    HUMAN PATHOLOGY, 2017, 60 : 16 - 23
  • [5] Systemic CD4 immunity: A powerful clinical biomarker for PD-L1/PD-1 immunotherapy
    Zuazo, Miren
    Arasanz, Hugo
    Bocanegra, Ana
    Chocarro, Luisa
    Vera, Ruth
    Escors, David
    Kagamu, Hiroshi
    Kochan, Grazyna
    EMBO MOLECULAR MEDICINE, 2020, 12 (09)
  • [6] PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes
    Li, Xia
    Zhong, Ting
    Tang, Rong
    Wu, Chao
    Xie, Yuting
    Liu, Fang
    Zhou, Zhiguang
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (06): : 1947 - 1956
  • [7] Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy
    Zuazo, Miren
    Arasanz, Hugo
    Bocanegra, Ana
    Fernandez, Gonzalo
    Chocarro, Luisa
    Vera, Ruth
    Kochan, Grazyna
    Escors, David
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [9] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [10] Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
    Fu, Mengdi
    Zhou, Huimei
    Yang, Jiaxin
    Cao, Dongyan
    Yuan, Zhen
    SCIENTIFIC REPORTS, 2025, 15 (01):